Innate and Autoimmunity in the Pathogenesis of Inherited Retinal Dystrophy.

Cells
T J Hollingsworth, Alecia K Gross

Abstract

Inherited retinal dystrophies (RDs) are heterogenous in many aspects including genes involved, age of onset, rate of progression, and treatments. While RDs are caused by a plethora of different mutations, all result in the same outcome of blindness. While treatments, both gene therapy-based and drug-based, have been developed to slow or halt disease progression and prevent further blindness, only a small handful of the forms of RDs have treatments available, which are primarily for recessively inherited forms. Using immunohistochemical methods coupled with electroretinography, optical coherence tomography, and fluorescein angiography, we show that in rhodopsin mutant mice, the involvement of both the innate and the autoimmune systems could be a strong contributing factor in disease progression and pathogenesis. Herein, we show that monocytic phagocytosis and inflammatory cytokine release along with protein citrullination, a major player in forms of autoimmunity, work to enhance the progression of RD associated with a rhodopsin mutation.

References

Apr 22, 2005·The Journal of Comparative Neurology·Anthony P NicholasScott R Barnum
May 26, 2006·Investigative Ophthalmology & Visual Science·Sanjoy K BhattacharyaJohn W Crabb
Jul 18, 2008·Progress in Retinal and Eye Research·Anneke I den HollanderFrans P M Cremers
Apr 25, 2009·IUBMB Life·Sanjoy K Bhattacharya
Jan 19, 2012·International Review of Cell and Molecular Biology·T J Hollingsworth, Alecia K Gross
Nov 24, 2012·Biopolymers·Kevin L Bicker, Paul R Thompson
Mar 5, 2013·Nature Structural & Molecular Biology·Nadia J KershawJeffrey J Babon
Apr 9, 2013·Experimental Eye Research·Vera L BonilhaJoe G Hollyfield
Aug 14, 2013·The Journal of Biological Chemistry·T J Hollingsworth, Alecia K Gross
Dec 3, 2013·Annals of the Rheumatic Diseases·Nishant Dwivedi, Marko Radic
Mar 29, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nishant DwivediMarko Radic
Mar 21, 2017·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Kasra A RezaeiRuikang K Wang
Aug 4, 2018·Investigative Ophthalmology & Visual Science·T J HollingsworthAlessandro Iannaccone
Feb 28, 2019·Proceedings of the National Academy of Sciences of the United States of America·Michael LandowskiCatherine Bowes Rickman
Sep 11, 2019·Progress in Retinal and Eye Research·Yusuke MurakamiKoh-Hei Sonoda
Oct 23, 2019·International Journal of Molecular Sciences·Teresa TsaiStephanie C Joachim

❮ Previous
Next ❯

Citations

Dec 6, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Albert M MaguireTomas S Aleman
May 11, 2021·Critical Reviews in Food Science and Nutrition·Kristin KruegerMarietta Zille

❮ Previous
Next ❯

Software Mentioned

SOCS3

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.